Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2009 (Vol. 29, No. 1)

BEN

URL:www.biosciednet.org
  • Thorough approach
  • Access not always clear
BEN is a portal of the National Science Digital Library (NSDL) with “10,187 reviewed resources covering 77 biological sciences topics.” What, you may wonder, is a “reviewed resource?” I’m glad you asked, but to answer it I must describe BEN first. Established by the American Association for the Advancement of Science in 1999, BEN (BioscienceEdNet) was designed with biological science education in mind. It provides free access to K-12 educators and college faculty to materials for use in the classroom, for use in preparing material for teaching, and for just about any teaching-related activity. Most of the material is free with registration, though there are some sections that require a paid subscription. Materials are reviewed by individual societies in the biological sciences for standards of quality and accuracy. Materials are accessible through a search engine and several browsing options.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »